IFM Investors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.72M | Buy |
124,259
+2,930
| +2% | +$229K | 0.09% | 202 |
|
|
2025
Q1 | $8.79M | Hold |
121,329
| – | – | 0.1% | 207 |
|
|
2024
Q4 | $8.98M | Sell |
121,329
-11,220
| -8% | -$831K | 0.09% | 204 |
|
|
2024
Q3 | $8.75M | Sell |
132,549
-1,435
| -1% | -$94.7K | 0.08% | 234 |
|
|
2024
Q2 | $12.4M | Buy |
133,984
+189
| +0.1% | +$17.5K | 0.13% | 155 |
|
|
2024
Q1 | $12.8M | Sell |
133,795
-1,770
| -1% | -$169K | 0.14% | 148 |
|
|
2023
Q4 | $10.3M | Buy |
135,565
+2,792
| +2% | +$213K | 0.13% | 165 |
|
|
2023
Q3 | $9.2M | Buy |
132,773
+4,340
| +3% | +$301K | 0.12% | 170 |
|
|
2023
Q2 | $12.1M | Buy |
128,433
+4,031
| +3% | +$380K | 0.16% | 129 |
|
|
2023
Q1 | $10.3M | Buy |
124,402
+3,271
| +3% | +$271K | 0.16% | 130 |
|
|
2022
Q4 | $9.04M | Buy |
121,131
+11,801
| +11% | +$880K | 0.15% | 142 |
|
|
2022
Q3 | $9.03M | Buy |
109,330
+1,686
| +2% | +$139K | 0.16% | 127 |
|
|
2022
Q2 | $10.2M | Buy |
107,644
+5,084
| +5% | +$483K | 0.18% | 119 |
|
|
2022
Q1 | $12.1M | Buy |
102,560
+19,122
| +23% | +$2.25M | 0.19% | 104 |
|
|
2021
Q4 | $10.8M | Buy |
83,438
+224
| +0.3% | +$29K | 0.2% | 100 |
|
|
2021
Q3 | $9.42M | Sell |
83,214
-245
| -0.3% | -$27.7K | 0.19% | 102 |
|
|
2021
Q2 | $8.64M | Buy |
83,459
+13,886
| +20% | +$1.44M | 0.18% | 119 |
|
|
2021
Q1 | $5.82M | Buy |
69,573
+9,554
| +16% | +$799K | 0.16% | 132 |
|
|
2020
Q4 | $5.48M | Buy |
60,019
+8,834
| +17% | +$806K | 0.17% | 122 |
|
|
2020
Q3 | $4.09M | Buy |
51,185
+12,319
| +32% | +$983K | 0.17% | 123 |
|
|
2020
Q2 | $2.69M | Sell |
38,866
-22,817
| -37% | -$1.58M | 0.14% | 149 |
|
|
2020
Q1 | $4.03M | Sell |
61,683
-2,289
| -4% | -$150K | 0.18% | 124 |
|
|
2019
Q4 | $4.98M | Sell |
63,972
-3,315
| -5% | -$258K | 0.18% | 127 |
|
|
2019
Q3 | $4.93M | Buy |
67,287
+23,469
| +54% | +$1.72M | 0.18% | 125 |
|
|
2019
Q2 | $2.7M | Buy |
43,818
+3,267
| +8% | +$201K | 0.15% | 147 |
|
|
2019
Q1 | $2.59M | Buy |
40,551
+4,020
| +11% | +$256K | 0.17% | 137 |
|
|
2018
Q4 | $1.87M | Buy |
36,531
+3,258
| +10% | +$166K | 0.15% | 150 |
|
|
2018
Q3 | $1.93M | Buy |
33,273
+4,758
| +17% | +$276K | 0.15% | 150 |
|
|
2018
Q2 | $1.38M | Buy |
28,515
+8,961
| +46% | +$435K | 0.13% | 170 |
|
|
2018
Q1 | $909K | Buy |
19,554
+1,902
| +11% | +$88.4K | 0.13% | 174 |
|
|
2017
Q4 | $663K | Buy |
17,652
+165
| +0.9% | +$6.2K | 0.1% | 219 |
|
|
2017
Q3 | $637K | Hold |
17,487
| – | – | 0.11% | 221 |
|
|
2017
Q2 | $689K | Buy |
17,487
+4,353
| +33% | +$172K | 0.12% | 194 |
|
|
2017
Q1 | $412K | Buy |
13,134
+4,887
| +59% | +$153K | 0.1% | 227 |
|
|
2016
Q4 | $258K | Buy |
+8,247
| New | +$258K | 0.12% | 224 |
|